课题基金 / 基金详情

Innate and Adaptive Immune Consequences of Necroptosis

Innate and Adaptive Immune Consequences of Necroptosis
坏死性凋亡的先天性和适应性免疫后果
批准号:
10043494
负责人:
Julie Magarian Blander
金额:
$25.43万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-06-17 至 2022-05-31
关键词:
Acute Lung InjuryAlzheimer&aposs DiseaseAmyotrophic Lateral SclerosisAnimal ModelAntigensApoptosisApoptoticAtherosclerosisAutoimmune DiseasesAutoimmune ProcessAutoimmunityBrain IschemiaCASP8 geneCD4 Positive T LymphocytesCardiovascular DiseasesCell DeathCell Differentiation processCell divisionCell membraneCell physiologyCellsCessation of lifeCharacteristicsChronicChronic lung diseaseComplexCrohn&aposs diseaseDevelopmentDietDigestive System DisordersDiseaseDown-RegulationEmbryoEnvironmental Risk FactorEpithelialEpithelial CellsEpitheliumEquilibriumEventFoundationsFunctional disorderGene Expression ProfileGene Expression ProfilingGenerationsGenetic Predisposition to DiseaseGenetic TranscriptionGenetically Engineered MouseHomeostasisHumanImmuneImmune ToleranceImmune systemImmunityImmunosuppressionIn VitroInfectionInfection ControlInflammationInflammation MediatorsInflammatoryInflammatory Bowel DiseasesInflammatory ResponseInjuryInnate Immune SystemIntestinesIschemiaKnowledgeLamina PropriaLife StyleLymphoid CellMalignant NeoplasmsMediatingMediator of activation proteinModelingMolecularMononuclearMucous MembraneMultiple SclerosisMusMyocardial IschemiaNamesNatureNerve DegenerationNormal tissue morphologyOrganOrgan ModelOrgan failureParkinson DiseasePathologicPathologyPathway interactionsPatientsPatternPhagocytesPhagocytosisPhosphotransferasesPhysiologyPopulationProcessProductionProtein-Serine-Threonine KinasesProteinsPublishingRIPK1 geneRIPK3 geneReportingSamplingSignal TransductionSmall IntestinesSterilitySwellingSystemic Lupus ErythematosusT cell differentiationTNF geneTherapeutic InterventionTissuesTransgenesUlcerative ColitisViralWorkadaptive immune responsebasechronic inflammatory diseasecommensal microbesdesigndimergenome wide association studyimprintin vivoinflammatory disease of the intestineinnate immune functionintestinal epitheliumintestinal homeostasismacrophagemesenteric lymph nodemicrobiotamouse modelnervous system disordernovelnovel therapeuticspathogenic microbepreservationprogramsreceptorrenal ischemiaresponse

项目摘要

项目成果

Julie Magarian Blander的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROPOSAL SUMMARY The innate immune system responds to perturbations in tissue homeostasis resultant from infection but also dying cells and tissue damage. Cells die by different modes of programmed cell death including apoptosis and necroptosis. Cell death by apoptosis is a normal component of healthy tissue physiology that is balanced by cell division and maintains normal tissue size and function. Cell death by apoptosis is tolerogenic and non- inflammatory, and contrasts with necroptosis, which is pathological and inflammatory. Necroptosis involves the formation of a complex of receptor interacting serine/threonine protein kinases RIPK1, RIPK3 and the necroptosis effector mixed lineage kinase domain-like protein (MLKL). Up until recently, necroptosis was thought to function primarily in the control of infection and mainly as a fail-safe strategy that counters viral blockade of apoptosis. Studies in mouse models, however, have shown that deficiency in components of the apoptosis machinery such as caspase-8 or FADD leads to embryonic lethality driven by necroptosis and dependent on RIPK3 and MLKL. Other studies using conditional deletion of caspase-8 or FADD in the intestinal epithelium revealed that blocking the pathways that mediate homeostatic apoptosis precipitates intestinal inflammation associated with elevated levels of RIPK3 and necroptosis. Indeed, a notable increase in programmed cell death of intestinal epithelial cells (IEC) has been reported in patients with inflammatory bowel disease (IBD), and this damage is associated with heightened inflammation and increased levels of tumor necrosis factor (TNF)-a, an important mediator of cell death. Using a novel mouse model where we can inducibly trigger necroptosis of IEC, we will determine how IEC necroptosis impacts intestinal homeostasis and we will define the nature of the inflammatory response. Our previous work has established that homeostatic apoptosis within the intestinal epithelium is a major driver of immune suppression and tolerance, imprinting intestinal mononuclear phagocytes (MNP) with ‘suppression of inflammation’ and ‘induction of regulatory CD4 T cell’ transcriptional signatures. Here we will define how necroptosis impacts MNP responses. We will examine the composition and characteristics of the small intestinal MNP population that responds to necroptotic IEC and decipher its function in various innate immune functions relating to the production of inflammatory mediators, modulation of innate lymphoid cell function as well as the CD4 T helper cell differentiation. The knowledge we gain will define how necroptosis drives inflammatory responses by innate and adaptive populations of cells, serve as a roadmap for the consequences of necroptosis in other tissues, and lay the foundation for the development of novel therapeutics for chronic inflammatory diseases such as IBD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mobilizing TAP-independent CD8 T cells through non-canonical cross-presentation
  • 批准号:
    10659785
  • 项目类别:
  • 资助金额:
    $67.69万
  • 财政年份:
    2023
  • 负责人:
    Julie Magarian Blander
  • 依托单位:
Modulating XIAP for the Treatment of Inflammatory Bowel Disease
  • 批准号:
    10727185
  • 项目类别:
  • 资助金额:
    $22.55万
  • 财政年份:
    2023
  • 负责人:
    Julie Magarian Blander
  • 依托单位:
Toll-like receptor control of endocytic antigen cross-presentation
  • 批准号:
    10735354
  • 项目类别:
  • 资助金额:
    $67.56万
  • 财政年份:
    2023
  • 负责人:
    Julie Magarian Blander
  • 依托单位:
Toll-like Receptor Control of MHC Class I Endocytosis
  • 批准号:
    10557150
  • 项目类别:
  • 资助金额:
    $21.19万
  • 财政年份:
    2022
  • 负责人:
    Julie Magarian Blander
  • 依托单位: